Cooperative Agreement U01PS005307
- The Centers for Disease Control and Prevention awarded a $2.954 million cooperative agreement to the Washington State Department of Health on September 30, 2025, under the HIV Prevention and Surveillance Activities—Health Department Based program (CFDA 93.940) for medical monitoring and HIV prevention and surveillance work through September 29, 2030. The award supports HIV behavioral surveillance, sexually transmitted disease surveillance network (SSuN) activities, and sexually transmitted...
- The Centers for Disease Control and Prevention awarded a cooperative agreement totaling $1,159,706 to the Philadelphia Department of Public Health Division of HIV Health on September 30, 2025, under the HIV/AIDS Surveillance program (CFDA 93.944). The award funds medical monitoring activities through September 29, 2030. Performance takes place in Pennsylvania. The HIV/AIDS Surveillance program strengthens surveillance operations to measure and evaluate HIV incidence and prevalence across the...
- The Centers for Disease Control and Prevention awarded a cooperative agreement to the City and County of San Francisco Public Health Department on September 30, 2025, totaling $643,882, obligated in full. The award funds the Medical Monitoring Project (MMP), a case surveillance activity that describes the behavioral and clinical characteristics of people with HIV in and out of care in San Francisco. The MMP uses surveillance-based sampling to supplement core HIV surveillance, generating data...
- This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...
- This Project Grant award from the Department of Health and Human Services' (HHS) Congressional Directives program (CFDA 93.493) provides $1,712,000.00 to the Lesbian & Gay Community Services Center Inc. (The Center) in New York City. The funding will support a multi-year project from September 30, 2023 to September 29, 2026 to deliver a comprehensive suite of social services and interventions tailored to the needs of the LGBTQ+ community. Key services include mental health counseling,...
- The Centers for Disease Control and Prevention awarded a $697,674 Cooperative Agreement to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 30, 2025, under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The award supports research examining high-dose medications for opioid use disorder and their effects on treatment retention, drug use patterns, and overdose risks amid the fentanyl crisis. Work is...
- The Centers for Disease Control and Prevention awarded a $1.397 million cooperative agreement to Boston Medical Center Corporation on September 30, 2025, to engage overdose survivors with the SafeSpot Hotline for secondary overdose prevention under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The cooperative agreement runs through September 29, 2030, with place of performance in Massachusetts. The award funds activities designed to reach...
- The Centers for Disease Control and Prevention awarded a $1.748 million Cooperative Agreement to the County of Los Angeles Department of Public Health on September 30, 2025, under the HIV Prevention and Surveillance Activities–Health Department Based program (CFDA 93.940). The award funds HIV prevention and surveillance activities conducted in California through September 29, 2030. The program assists states and political subdivisions in establishing and maintaining HIV prevention and...
- Federal Cooperative Agreement Summary The Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS awarded a $1,034,315 Cooperative Agreement to the Florida Department of Health, Office of Deputy Secretary For Operations, effective September 30, 2025, through September 29, 2030, under the HIV Prevention and Surveillance Activities—Health Department Based program (CFDA 93.940). The Florida Department of Health will conduct the Medical Monitoring Project, collecting behavioral...
- The Centers for Disease Control and Prevention awarded Houston Department of Health and Human Services a $1.463690 million cooperative agreement on September 30, 2025, to implement the Medical Monitoring Project in Houston and Harris County, Texas, under CFDA 93.940 (HIV Prevention and Surveillance Activities—Health Department Based). The Medical Monitoring Project is a key component of the National HIV Surveillance System designed to inform local and national HIV prevention and treatment...
The Centers for Disease Control and Prevention awarded a Cooperative Agreement to Fenway Community Health Center, Inc. on September 1, 2026, in the amount of $1.2 million to integrate PEP (post-exposure prophylaxis) packs into existing sexual health clinical care for gay, bisexual, and men who have sex with men (GBMSM). Fenway Community Health Center will deliver this work in Boston, Massachusetts through August 31, 2030, under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084). The cooperative agreement structure indicates substantive involvement by CDC in the award's execution beyond funding. Fenway Community Health Center, a Boston-based non-profit established in 2006, provides healthcare services to LGBTQ+ populations and individuals living with HIV/AIDS. The organization has prior experience with CDC awards and participates in research networks addressing HIV prevention and care, including collaborations with academic institutions such as University of Massachusetts Medical School and Boston University.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 8/27/26 |